Multiple sclerosis (MS) has long been regarded as a disease with different subtypes such as "relapsing" or "progressive." An international study, published on August 20, 2025, in Nature Medicine under ...
Secondary progressive multiple sclerosis (SPMS) is a chronic form of disease that occurs after relapsing-remitting MS, with a progressive disease course, and its pathogenesis remains unclear. CX3C ...
The symptoms and pathophysiology of primary progressive multiple sclerosis (PPMS) differ from other forms. For instance, patients with PPMS tend to have more sensory symptoms, like weakness, than ...
Mouse models are incredibly valuable to scientists studying human diseases like the neurodegenerative autoimmune condition multiple sclerosis (MS). There’s only one problem: Mice don’t develop MS.
Multiple sclerosis (MS) is an autoimmune disorder of the central nervous system (CNS) caused by nerve inflammation that affects over 2 million people globally. Bromodomain and extra-terminal domain ...
To provide the right treatment for MS, it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently recognized on average three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results